Evaluation of Periapical Healing Following Endodontic Microsurgery With Leukocyte and Platelet Rich Fibrin (L-PRF)

Last updated: August 20, 2025
Sponsor: University of Pennsylvania
Overall Status: Active - Recruiting

Phase

N/A

Condition

Periodontitis

Treatment

Leukocyte and Platelet Rich Fibrin

Clinical Study ID

NCT06545084
855857
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The purpose of the study is to evaluate peri-radicular healing after root-end surgery using Leukocyte and Platelet Rich Fibrin. The study population includes patients diagnosed with persistent periapical pathology and scheduled for Endodontic Microsurgery at the University of Pennsylvania School of Dental Medicine, Department of Endodontics. Patients undergoing routine endodontic microsurgery and who meet the inclusion criteria will be given the opportunity to opt in to receive L-PRF in the osteotomy site to promote bone formation. Healing will be assessed radiographically and clinically at six, twelve, eighteen, and twenty-four months.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Provision of signed and dated informed consent form.

  2. Stated willingness to comply with all study procedures and availability for theduration of the study, including the follow-up visits.

  3. Male or Female age >18 years old.

  4. In good general health (ASA 2 or less) with no contraindications for EndodonticMicrosurgery.

  5. Persistent endodontic periapical pathology Class A, B, or C according to the Kim andKratchman classification (5)

  6. Intact coronal restorations with no evidence of leakage or caries under therestoration.

Exclusion

Exclusion Criteria:

  1. Minors.

  2. Suspected root fractures.

  3. ASA classification 3 or greater.

  4. Periapical pathology Class D, E, or F according to the Kim and Kratchmanclassification (5).

  5. Patients with history of Oral or IV Bisphosphonate use.

  6. Patients may be excluded if their treatment team do not believe Endodonticmicrosurgery and L-PRF graft is in the patient's best interests.

Study Design

Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Leukocyte and Platelet Rich Fibrin
Phase:
Study Start date:
August 01, 2024
Estimated Completion Date:
June 30, 2026

Connect with a study center

  • Penn Dental Medicine

    Philadelphia, Pennsylvania 19104
    United States

    Site Not Available

  • Penn Dental Medicine

    Philadelphia 4560349, Pennsylvania 6254927 19104
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.